Back
Xtacy Therapeutics Stock Price Chart
Sponsored
XTCY.CX
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
XTCY.CX
Xtacy Therapeutics
Last Price:
0.02
Seasonality Move:
43.46%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.
Xtacy Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.03 | Sell |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.04 | Sell |
200-day SMA: | 0.04 | Sell |
8-day EMA: | 0.03 | Sell |
20-day EMA: | 0.03 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.05 | Sell |
Xtacy Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 38.74 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.02 - 0.04) | Sell |
Bollinger Bands (100): | (0.03 - 0.05) | Sell |
Xtacy Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Xtacy Therapeutics Stock
Is Xtacy Therapeutics Stock a Buy?
- Xtacy Therapeutics share price is 0.02 while XTCY.CX 8-day simple moving average is 0.03, which is a Sell signal.
- The stock price of XTCY.CX is 0.02 while Xtacy Therapeutics 20-day SMA is 0.03, which makes it a Sell.
- Xtacy Therapeutics 50-day simple moving average is 0.04 while XTCY.CX share price is 0.02, making it a Sell technically.
- XTCY.CX stock price is 0.02 and Xtacy Therapeutics 200-day simple moving average is 0.04, creating a Sell signal.
XTCY.CX Technical Analysis vs Fundamental Analysis
Sell
20
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy or a Sell?
-
Xtacy Therapeutics stock is rated a Sell
The current Xtacy Therapeutics [XTCY.CX] share price is $0.02. The Score for XTCY.CX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Xtacy Therapeutics Stock Info
Market Cap:
1.16M
Price in USD:
0.02
Share Volume:
0
Xtacy Therapeutics 52-Week Range
52-Week High:
0.12
52-Week Low:
0.02
Sell
20
Xtacy Therapeutics (XTCY.CX)
is a Sell
Xtacy Therapeutics Share Price Forecast
-
What is the Xtacy Therapeutics stock price today?
The Xtacy Therapeutics stock price is 0.02 USD today. -
Will XTCY.CX stock go up or go down?
Xtacy Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Xtacy Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xtacy Therapeutics is overvalued.
Is Xtacy Therapeutics Stock a Buy?
- Xtacy Therapeutics share price is 0.02 while XTCY.CX 8-day exponential moving average is 0.03, which is a Sell signal.
- The stock price of XTCY.CX is 0.02 while Xtacy Therapeutics 20-day EMA is 0.03, which makes it a Sell.
- Xtacy Therapeutics 50-day exponential moving average is 0.03 while XTCY.CX share price is 0.02, making it a Sell technically.
- XTCY.CX stock price is 0.02 and Xtacy Therapeutics 200-day simple moving average is 0.05, creating a Sell signal.
Technical Analysis of Xtacy Therapeutics
Should I short Xtacy Therapeutics stock?
- XTCY.CX Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Xtacy Therapeutics is a Sell
- Xtacy Therapeutics Relative Strength Index (RSI) is 38.74, which suggest Xtacy Therapeutics is oversold
- The Bollinger Bands (25) for Xtacy Therapeutics is (0.02 - 0.04), which suggest Xtacy Therapeutics is a Sell
- The Bollinger Bands (100) for Xtacy Therapeutics is (0.03 - 0.05), which suggest Xtacy Therapeutics is a Sell
* Xtacy Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.